Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tafamidis in ATTR-PN Phase IV Single-Arm Study
CTR20200818Phase 4Completed
- Sponsor
- ---
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tafamidis in transthyretin amyloidosis (ATTR), sponsored by ---. Started Aug 2020; status: completed.
02
Drugs
tafamidis
03
Conditions
transthyretin amyloidosis (ATTR)
Beyond the preview
Go deeper on CTR20200818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200818.